glp-1 agonists and fertility GLP-1: A Game Changer for Weight Loss The hidden impact of GLP‐1
Description
PBPK, physiologically based pharmacokinetics
GIP and the Central Nervous System (CNS) Emerging evidence suggests that GIP analogs may exhibit neuroprotective properties in murine models of neurodegenerative disorders, including Alzheimers disease and Parkinsons disease [110]
As research continues, these medications may become an important tool for managing a wide range of conditions, from metabolic and cardiovascular health to neuroinflammation and mast cell disorders
GLP-1 oxidates fatty acids and reduces its influx into hepatocytes, inhibiting NAFLD
Research is ongoing
